Boyds reports record-breaking growth 12 months on from Queen’s Award
Boyds has reported record-breaking growth in its overseas turnover in the 12 months since it was recognised with one of the UK’s most prestigious awards, The Queen’s Award for Enterprise. Since receiving the Queen’s Award for Enterprise, International Trade for Outstanding Short-Term Growth in overseas in April 2018, Boyds has also grown its team with […]
Boyds bolsters Regulatory Affairs team with appointment of Claire Scruton
Boyds has announced a key appointment in support of its continuing growth plans, welcoming Claire Scruton as Senior Manager of CMC Regulatory Affairs. At Boyds, Claire will provide strategic regulatory CMC advice and operational support across a range of therapeutic areas and development stages for ATMPs, biologics and new chemical entities. A CMC regulatory affairs […]
American Society of Gene and Cell Therapy Annual Meeting, Washington
Professor Alan Boyd will be chairing the Audentes Symposium session at the American Society of Gene and Cell Therapy (ASGCT) annual meeting in Washington on the 1st May 2019. Audentes Therapeutics, Inc. is a leading AAV-based genetic medicines company focused on developing and commercialising innovative products for serious rare neuromuscular diseases, will be giving a […]
Boyds strengthens Regulatory team with appointment of Sabine Rühle
Boyds has announced a key appointment in support of its continued growth plans, welcoming Dr Sabine Rühle as Senior Associate of Regulatory Affairs. A member of the Organisation of Professionals in Regulatory Affairs (MTOPRA), Sabine joins from Pharmaceutical Product Development, where she was Senior Regulatory Affairs Specialist and coordinated global CTA submissions for a variety of […]
Boyds builds on growth plans with clinical operations hire
Boyds has further strengthened its clinical operations offering with the appointment of Pippa Bjaaland as a Senior Clinical Research Associate (CRA), as part of an ongoing recruitment drive to grow in-house CRA expertise. Pippa brings more than five years’ industry experience in clinical operations and joins Boyds from Syneos Health where she was a Senior […]
New Dublin office in Ireland for Boyds
Boyds has opened an office in Dublin, Ireland in a step that will ensure the continuity of service to its clients once the UK leaves the EU. The new office will be based at DCU Invent on the Dublin City University Campus. Professor Alan Boyd, Founder and CEO of Boyds, commented: “The UK’s departure from […]
Professor Alan Boyd appointed as Non-Executive Director at Clinigen Group
Boyds’ CEO, Professor Alan Boyd, has been appointed as a Non-Executive Director at global pharmaceutical and services company, Clinigen Group. Clinigen’s unique combination of businesses focus on providing ethical access to medicines, with its mission being to deliver the right medicine to the right patient at the right time through three areas of global medicine […]
Boyds presented with Queen’s Award for Enterprise
Boyds has been presented with one of the UK’s most prestigious business awards – The Queen’s Award for Enterprise, International Trade for Outstanding Short-Term Growth in overseas sales for the last three years, and specifically for its work in cell and gene therapy. Boyds was awarded the accolade by Her Majesty’s Lord Lieutenant of Cheshire, […]
Boyds to chair and present at TOPRA Symposium
This year’s TOPRA Symposium will take place this October in Stockholm and is held in partnership with the Swedish MPA. The three-day symposium will cover three separate tracks: human medicines, medical devices/IVDs and, veterinary medicines. On day three of the symposium (3rd October) an additional three parallel topic tracks are being run for small and […]
Boyds shortlisted as an OBN Award finalist
Boyds has been shortlisted as a finalist in the Best Sector Support Organisation category at the 2018 OBN Awards. CEO and Founder, Professor Alan Boyd commented: “The award for Best Sector Support Organisation recognises outstanding levels of support or service to companies in the life sciences sector. It is a great honour to be shortlisted.” Now in […]
